Merit Medical
Merit Medical Systems, Inc., commonly referred to as Merit Medical, is a leading global provider of medical devices headquartered in the United States. Founded in 1987, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Specialising in interventional medicine, Merit Medical focuses on areas such as cardiology, radiology, and pain management. The company is renowned for its innovative core products, including catheter systems, access devices, and fluid management solutions, which are designed to enhance patient outcomes and streamline clinical procedures. Merit Medical's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, with notable achievements in expanding its product portfolio and global reach.
DitchCarbon Score
How does Merit Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merit Medical's score of 25 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merit Medical's reported carbon emissions
In 2023, Merit Medical reported total carbon emissions of approximately 17,656,000 kg CO2e. This figure includes about 3,072,000 kg CO2e from Scope 1 emissions and approximately 14,584,000 kg CO2e from Scope 2 emissions. Over the past few years, the company has demonstrated a commitment to reducing its carbon footprint, with emissions decreasing from about 20,897,000 kg CO2e in 2020 to the latest figure in 2023. Merit Medical's emissions data shows a consistent reduction trend, with total emissions dropping from approximately 19,150,000 kg CO2e in 2021 and 17,239,000 kg CO2e in 2022. The company has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, indicating a potential area for future commitment. Overall, Merit Medical's focus on reducing its Scope 1 and Scope 2 emissions reflects a growing awareness of climate impact within the medical device industry, aligning with broader sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 3,500,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 20,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 10,446,770 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merit Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
